PM Prime Medicine, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Prime Medicine, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €527.4m. The latest transaction was reported on 5 August 2025 (Acquisition). Among the most active insiders: GV 2019 GP, L.L.C.. Every trade is openly available.
Analyst consensus: bullish or bearish? Analysts rate Prime Medicine, Inc. Buy (bullish), based on 10 analysts. Average price target: US$7.12.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 August 2025
All Executives43 Thresholds0 Prospectus0 Other0
Declarations 43 total
▲ 10% Owner · Executives · 1 Aug 2025
1,500,000 shares @ US$3.30 100.0% of flow Common Stock SEC:0001415889-25-021025:0
Canonical exit: 30 Oct 2025 (T+90) ▲ Director · Executives · 1 Aug 2025
3,030,300 shares @ US$3.30 32.0% of flow Common Stock SEC:0001062993-25-013462:0
Canonical exit: 30 Oct 2025 (T+90) 3,030,300 shares @ US$3.30 32.0% of flow Common Stock SEC:0001062993-25-013461:0
Canonical exit: 30 Oct 2025 (T+90) 3,030,300 shares @ US$3.30 32.0% of flow Common Stock SEC:0001062993-25-013460:0
Canonical exit: 30 Oct 2025 (T+90) 21,000 shares @ US$2.5157 32.0% of flow Common Stock SEC:0001628280-25-033754:0
Canonical exit: 28 Sept 2025 (T+90) 21,000 shares @ US$2.162 41.1% of flow Common Stock SEC:0001628280-25-032626:0
Canonical exit: 21 Sept 2025 (T+90) 21,000 shares @ US$1.4855 48.1% of flow Common Stock SEC:0001628280-25-031637:0
Canonical exit: 14 Sept 2025 (T+90) 21,000 shares @ US$1.5995 100.0% of flow Common Stock SEC:0001628280-25-031045:0
Canonical exit: 9 Sept 2025 (T+90) ▲ Chief Executive Officer · Executives · 21 May 2025
125,000 shares @ US$1.1772 100.0% of flow Common Stock SEC:0001894562-25-000026:0
Canonical exit: 19 Aug 2025 (T+90) ▲ Chief Business Officer · Executives · 20 May 2025
20,000 shares @ US$1.1895 100.0% of flow Common Stock SEC:0001894562-25-000030:0
Canonical exit: 18 Aug 2025 (T+90) ▲ Chief Technical Officer · Executives · 21 May 2025
100,000 shares @ US$1.13 100.0% of flow Common Stock SEC:0001894562-25-000028:0
Canonical exit: 19 Aug 2025 (T+90) ● See Remarks · Executives · 8 Oct 2024
226,925 shares 0Common Stock SEC:0001894562-24-000043:0
● See Remarks · Executives · 5 Jun 2024
250,000 shares 0Common Stock SEC:0001894562-24-000026:0
3,200,000 shares @ US$6.25 100.0% of flow Common Stock SEC:0001062993-24-003739:0
Canonical exit: 15 May 2024 (T+90) ▲ Director · Executives · 15 Feb 2024
3,200,000 shares @ US$6.25 100.0% of flow Common Stock SEC:0001062993-24-003740:0
Canonical exit: 15 May 2024 (T+90) 3,200,000 shares @ US$6.25 100.0% of flow Common Stock SEC:0001062993-24-003738:0
Canonical exit: 15 May 2024 (T+90) ● See Remarks · Executives · 11 Nov 2023
7,500 shares 0Common Stock SEC:0001894562-23-000034:0
1,000,000 shares 0Common Stock SEC:0001894562-23-000032:0
1,000,000 shares 0Common Stock SEC:0001894562-23-000030:0
37,405 shares 0Common Stock SEC:0001209191-23-039122:0
66,659 shares 0Common Stock SEC:0001209191-23-038363:0
28,100 shares 0Common Stock SEC:0001209191-23-037334:0
▼ 10% Owner · Executives · 9 Jun 2023
15,672 shares @ US$14.4834 5.4% of flow Common Stock SEC:0001209191-23-036666:1
▼ 10% Owner · Executives · 12 Jun 2023
16,031 shares @ US$14.9804 5.7% of flow Common Stock SEC:0001209191-23-036666:3
15,672 shares 0Common Stock SEC:0001209191-23-036666:0
25 of 43 declarations
Load more (18 remaining) 关于 Prime Medicine, Inc. Prime Medicine, Inc. 是一家生物技术公司，专注于开发基因疗法以治疗遗传疾病。它采用先进技术设计创新疗法。